ATE306275T1 - Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten - Google Patents

Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten

Info

Publication number
ATE306275T1
ATE306275T1 AT00981496T AT00981496T ATE306275T1 AT E306275 T1 ATE306275 T1 AT E306275T1 AT 00981496 T AT00981496 T AT 00981496T AT 00981496 T AT00981496 T AT 00981496T AT E306275 T1 ATE306275 T1 AT E306275T1
Authority
AT
Austria
Prior art keywords
lithium
viral infections
contain
pharmaceutical preparations
loop diuretic
Prior art date
Application number
AT00981496T
Other languages
English (en)
Inventor
Christopher Edward Hartley
Original Assignee
Henderson Morley Res & Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9930813.2A external-priority patent/GB9930813D0/en
Priority claimed from GB0000683A external-priority patent/GB0000683D0/en
Priority claimed from GB0023200A external-priority patent/GB0023200D0/en
Application filed by Henderson Morley Res & Dev Ltd filed Critical Henderson Morley Res & Dev Ltd
Application granted granted Critical
Publication of ATE306275T1 publication Critical patent/ATE306275T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00981496T 1999-12-30 2000-12-13 Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten ATE306275T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9930813.2A GB9930813D0 (en) 1999-10-15 1999-12-30 Anti-viral treatment
GB0000683A GB0000683D0 (en) 1999-10-15 2000-01-12 Antiviral treatment
GB0023200A GB0023200D0 (en) 1999-12-30 2000-09-21 Synergistic treatment of DNA viral infections
PCT/GB2000/004790 WO2001049300A2 (en) 1999-12-30 2000-12-13 Combinations for the treatment of dna viral infections comprising a loop diuretic and lithium

Publications (1)

Publication Number Publication Date
ATE306275T1 true ATE306275T1 (de) 2005-10-15

Family

ID=27255466

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00981496T ATE306275T1 (de) 1999-12-30 2000-12-13 Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten

Country Status (9)

Country Link
US (2) US20030049331A1 (de)
EP (1) EP1242096B1 (de)
JP (1) JP2003519186A (de)
KR (1) KR20020073156A (de)
CN (1) CN1213757C (de)
AT (1) ATE306275T1 (de)
AU (1) AU1873101A (de)
DE (1) DE60023180D1 (de)
WO (1) WO2001049300A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1242119E (pt) * 1999-12-30 2004-08-31 Henderson Morley Res & Dev Ltd Combinacoes para o tratamento de infeccoes por virus adn incluindo um diuretico de ansa e um glicosido cardiotonico
ATE435019T1 (de) * 2000-09-21 2009-07-15 Henderson Morley Res & Dev Ltd Diuretikum oder sulfonylharnstoff zur benutzung in antiviraler behandlung
MXPA05008527A (es) 2003-02-12 2006-03-08 Univ Georgetown Uso de artemisinina para tratar tumores inducidos por virus oncogenicos y para tratar infecciones virales.
GB2413282B (en) * 2004-04-23 2009-01-14 Henderson Morley Plc DNA Viral Infections
GB0616451D0 (en) * 2006-08-18 2006-09-27 Henderson Morley Plc Dna viral infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU556817B2 (en) * 1982-02-03 1986-11-20 Efamol Limited Topical application of a lithium salt and dihomo-alpha- linolenic acid
GB8320203D0 (en) * 1983-07-27 1983-09-01 Horrobin D F Anti-viral compositions
GB9023701D0 (en) * 1990-10-31 1990-12-12 Efamol Holdings Medical treatment
DE4127469A1 (de) * 1991-08-20 1993-02-25 Peter Prof Dr Med Eckert Arzneimittel und ihre verwendung
AU681629B2 (en) * 1993-03-12 1997-09-04 Keele University Therapeutic compositions containing a lithium compound and silica
ATE215106T1 (de) * 1993-12-01 2002-04-15 Bioartificial Gel Technologies Inc Hydrogel auf basis von albumin
ATE435019T1 (de) * 2000-09-21 2009-07-15 Henderson Morley Res & Dev Ltd Diuretikum oder sulfonylharnstoff zur benutzung in antiviraler behandlung

Also Published As

Publication number Publication date
CN1414859A (zh) 2003-04-30
AU1873101A (en) 2001-07-16
US20030049331A1 (en) 2003-03-13
EP1242096A2 (de) 2002-09-25
WO2001049300A2 (en) 2001-07-12
US20060029684A1 (en) 2006-02-09
KR20020073156A (ko) 2002-09-19
EP1242096B1 (de) 2005-10-12
JP2003519186A (ja) 2003-06-17
CN1213757C (zh) 2005-08-10
DE60023180D1 (de) 2006-02-23
WO2001049300A3 (en) 2002-07-11

Similar Documents

Publication Publication Date Title
ATE261737T1 (de) Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und ein herzglykosid enthalten
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
ATE296634T1 (de) (s,s)-reboxetin zur behandlung von fibromyalgie und anderen somatoformen störungen
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE69830728D1 (de) Arzneimittel zur behandlung von häufigem wasserlassen und harninkontinenz
DE69830751D1 (de) Polyaromatische Verbindungen zur Behandlung von Herpes-Infektionen
DE3785388D1 (de) Antivirale peptide und mittel zur behandlung von herpes.
NO934706L (no) Substituerte 4-fenyl-pyridoner og 4-fenyl-2-alkoksypyridiner
ATE298339T1 (de) ß3,7-DIAZABICYCLO(3.3.0)OCTANE UND DEREN VERWENDUNG BEI DER BEHANDLUNG VON HERZRHYTHMUSSTÖRUNGENß
MX9101958A (es) Inhibidores de acat de urea de aminosulfonilo
PT1001775E (pt) Medicamento contendo ioimbina e arginina para tratamento de disfuncao erectil
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE69939075D1 (de) Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
DE69916488D1 (de) Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren
DE69004451D1 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
DE60023180D1 (de) Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten
DE60006412D1 (de) Oxazinochinolone zur behandlung von viralen infektionen
DE68907569D1 (de) Mittel zur behandlung oder vorbeugung von aids.
MA26650A1 (fr) Oxo-thia -azabicyclooctenes, preparations pharmaceutiques les contenant, et leur utilisation pour le traitement et la prophylaxie de maladies infectieuses.
DE69838980D1 (de) Kombination von product r mit einem antiviralen mittel in der behandlung von hiv infektionen
DE60024969D1 (de) 2-methyl-3-butenyl-1-pyrophosphorsäuresalze und mittel zur behandlung von lymphozyten
ATE255417T1 (de) Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen
DE69825307D1 (de) Verwendung von protein h als zytostattischer wirkstoff
BR0012380A (pt) 2-amino-benzoxazinonas para o tratamento de vìrus do herpes simples
DE58902466D1 (de) Acyl-carnitin zur behandlung und zur verhuetung von virusinfektionen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties